Crossmark

Efficacy of transarterial therapy combined with first-line tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a network meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12957-023-03098-3

Published Online: 2023-07-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hu, Lingbo

Lin, Jiangying

Shi, Xingpeng

Wang, Aidong
License Information

Text and Data Mining valid from 2023-07-21

Version of Record valid from 2023-07-21
More Information

Article History

Received: 11 March 2023

Accepted: 12 July 2023

First Online: 21 July 2023

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below